Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0870420070110030048
Korean Journal of Hepato-Biliary-Pancreatic Surgery
2007 Volume.11 No. 3 p.48 ~ p.53
Surgical Treatment of Primary Neuroendocrine Tumors of the Liver
Kim Chan-Wook

Lee Sung-Gyu
Yu Eun-Sil
Hwang Shin
Lee Young-Joo
Park Kwang-Min
Kim Ki-Hun
Ahn Chul-Soo
Moon Ki-Myung
Lee Hee-Jin
Abstract
Purpose: Primary neuroendocrine tumor (PNET) of the liver is a very rare neoplasm. This study was conducted to analyze the clinical experience of 8 hepatic PNET cases.

Methods: Four male and 4 female patients with a mean age of 50.4 ¡¾ 9.5 years (range 37-64 years) underwent liver resection for hepatic PNET between January 1997 and December 2006. The diagnosis was confirmed histologically using light microscopy and immunohistochemistry in the absence of an alternative primary site

Results: Curative resection was achieved in 6 of the 8 patients, and 5 of the patients were alive and disease free after a mean follow-up period of 47.6 months. However, 3 patients died 3, 5 and 26 months after surgery due to multiple liver metastasis. A proliferative index of Ki67 appeared to indicate a significant risk factor for tumor recurrence. Additionally, recurrence occurred in 1 of the 6 patients that underwent curative resection during the follow-up period. Overall, both the 5-year recurrence rate and the 5-year survival rate were 50%.

Conclusions: Active exclusion of an extrahepatic primary site is essential for diagnosis of hepatic PNET. The primary treatment for PNET is curative liver resection, and a proliferative index of Ki67 appears to be a prognostic factor for tumor recurrence.
KEYWORD
Neuroendocrine tumor, liver resection, carcinoid, Ki67
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø